Dynamic simulation of cardiolipin remodeling: Greasing the wheels for an interpretative approach to lipidomics

Journal of Lipid Research

Volumn 51, Issue 8, 2010, Pages 2153-2170

  Kiebish, Michael A ^a   Bell, Rob ^b   Yang, Kui ^a   Phan, Toan ^b   Zhao, Zhongdan ^a   Ames, William ^b   Seyfried, Thomas N ^b   Gross, Richard W ^a   Chuang, Jeffrey H ^b   Han, Xianlin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

Barth syndrome; Bioinformatics; Shotgun lipidomics

Indexed keywords

ACYLTRANSFERASE; CARDIOLIPIN; MITOCHONDRIAL PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID ANALYSIS; LIPID METABOLISM; LIPIDOMICS; LIPOGENESIS; MALE; MATHEMATICAL COMPUTING; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; CHEMISTRY; ENZYME SPECIFICITY; MASS SPECTROMETRY; METABOLISM; REPRODUCIBILITY; STEREOISOMERISM;

ACYLTRANSFERASES; ANIMALS; CARDIOLIPINS; MALE; MASS SPECTROMETRY; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM; SUBSTRATE SPECIFICITY;

EID: 77956809106     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M004796     Document Type: Article

References (64)

1. Han, X., and R. W. Gross. 2005. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24: 367-412.
2. Dennis, E. A. 2009. Lipidomics joins the omics evolution. Proc. Natl. Acad. Sci. USA. 106: 2089-2090.
3. Niemela, P. S., S. Castillo, M. Sysi-Aho, and M. Oresic. 2009. Bioinformatics and computational methods for lipidomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2855-2862.
4. Han, X., and R. W. Gross. 2005. Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes. Expert Rev. Proteomics. 2: 253-264.
5. Yang, K., H. Cheng, R. W. Gross, and X. Han. 2009. Automated lipid identification and quantification by multidimensional mass spectrometry- based shotgun lipidomics. Anal. Chem. 81: 4356-4368.
6. Seppanen-Laakso, T., and M. Oresic. 2009. How to study lipidomes. J. Mol. Endocrinol. 42: 185-190.
7. Fahy, E., D. Cotter, R. Byrnes, M. Sud, A. Maer, J. Li, D. Nadeau, Y. Zhau, and S. Subramaniam. 2007. Bioinformatics for lipidomics. Methods Enzymol. 432: 247-273.
8. Wheelock, C. E., S. Goto, L. Yetukuri, F. L. D'Alexandri, C. Klukas, F. Schreiber, and M. Oresic. 2009. Bioinformatics strategies for the analysis of lipids. Methods Mol. Biol. 580: 339-368.
9. Song, H., J. Ladenson, and J. Turk. 2009. Algorithms for automatic processing of data from mass spectrometric analyses of lipids. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2847-2854.
10. Forrester, J. S., S. B. Milne, P. T. Ivanova, and H. A. Brown. 2004. Computational lipidomics: a multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction. Mol. Pharmacol. 65: 813-821.
11. Hoch, F. L. 1992. Cardiolipins and biomembrane function. Biochim. Biophys. Acta. 1113: 71-133.
12. Kiebish, M. A., X. Han, H. Cheng, J. H. Chuang, and T. N. Seyfried. 2008. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J. Lipid Res. 49: 2545-2556.
13. Chicco, A. J., and G. C. Sparagna. 2007. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am. J. Physiol. Cell Physiol. 292: C33-C44.
14. Jiang, F., M. T. Ryan, M. Schlame, M. Zhao, Z. Gu, M. Klingenberg, N. Pfanner, and M. L. Greenberg. 2000. Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J. Biol. Chem. 275: 22387-22394.
15. Han, X., K. Yang, J. Yang, H. Cheng, and R. W. Gross. 2006. Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples. J. Lipid Res. 47: 864-879.
16. Cheng, H., D. J. Mancuso, X. Jiang, S. Guan, J. Yang, K. Yang, G. Sun, R. W. Gross, and X. Han. 2008. Shotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodeling. Biochemistry. 47: 5869-5880. (Pubitemid 351747066)
17. Han, X., J. Yang, K. Yang, Z. Zhao, D. R. Abendschein, and R. W. Gross. 2007. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry. 46: 6417-6428.
18. Kiebish, M. A., X. Han, H. Cheng, and T. N. Seyfried. 2009. In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours. ASN Neuro. 1: e00011.
19. Schlame, M., and M. Ren. 2006. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 580: 5450-5455.
20. Hauff, K. D., and G. M. Hatch. 2006. Cardiolipin metabolism and Barth Syndrome. Prog. Lipid Res. 45: 91-101.
21. Li, G., S. Chen, M. N. Thompson, and M. L. Greenberg. 2007. New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome. Biochim. Biophys. Acta. 1771: 432-441.
22. Houtkooper, R. H., and F. M. Vaz. 2008. Cardiolipin, the heart of mitochondrial metabolism. Cell. Mol. Life Sci. 65: 2493-2506.
23. Xu, Y., A. Malhotra, M. Ren, and M. Schlame. 2006. The enzymatic function of tafazzin. J. Biol. Chem. 281: 39217-39224.
24. Xu, Y., R. I. Kelley, T. J. Blanck, and M. Schlame. 2003. Remodeling of cardiolipin by phospholipid transacylation. J. Biol. Chem. 278: 51380-51385.
25. Kiebish, M. A., X. Han, H. Cheng, J. H. Chuang, and T. N. Seyfried. 2008. Brain mitochondrial lipid abnormalities in mice susceptible to spontaneous gliomas. Lipids. 43: 951-959.
26. Kiebish, M. A., X. Han, H. Cheng, A. Lunceford, C. F. Clarke, H. Moon, J. H. Chuang, and T. N. Seyfried. 2008. Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J. Neurochem. 106: 299-312.
27. Pon, L. A., and E. A. Schon, editors. 2001. Mitochondria. San Diego, CA, Academic Press.
28. Han, X., J. Yang, H. Cheng, H. Ye, and R. W. Gross. 2004. Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. Anal. Biochem. 330: 317-331.
29. Han, X., K. Yang, and R. W. Gross. 2008. Microfluidics-based electrospray ionization enhances the intrasource separation of lipid classes and extends identification of individual molecular species through multi-dimensional mass spectrometry: development of an automated high-throughput platform for shotgun lipidomics. Rapid Commun. Mass Spectrom. 22: 2115-2124.
30. Yang, K., Z. Zhao, R. W. Gross, and X. Han. 2009. Systematic analysis of choline-containing phospholipids using multi-dimensional mass spectrometry-based shotgun lipidomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2924-2936.
31. Han, X., and R. W. Gross. 2003. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 44: 1071-1079.
32. Yang, K., Z. Zhao, R. W. Gross, and X. Han. 2007. Shotgun lipidomics identifies a paired rule for the presence of isomeric ether phospholipid molecular species. PLoS ONE. 2: e1368.
33. Cheng, H., X. Jiang, and X. Han. 2007. Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study. J. Neurochem. 101: 57-76.
34. Sun, G., K. Yang, Z. Zhao, S. Guan, X. Han, and R. W. Gross. 2007. Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. Anal. Chem. 79: 6629-6640.
35. Sun, G., K. Yang, Z. Zhao, S. Guan, X. Han, and R. W. Gross. 2008. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of cellular glycerophospholipids enabled by multiplexed solvent dependent analyte-matrix interactions. Anal. Chem. 80: 7576-7585.
36. Cheng, H., G. Sun, K. Yang, R. W. Gross, and X. Han. 2010. Selective desorption/ionization of sulfatides by MALDI-MS facilitated using 9-aminoacridine as matrix. J. Lipid Res. 51: 1599-1609.
37. Rustow, B., M. Schlame, H. Rabe, G. Reichmann, and D. Kunze. 1989. Species pattern of phosphatidic acid, diacylglycerol, CDP-diacylglycerol and phosphatidylglycerol synthesized de novo in rat liver mitochondria. Biochim. Biophys. Acta. 1002: 261-263.
38. Houtkooper, R. H., M. Turkenburg, B. T. Poll-The, D. Karall, C. Perez-Cerda, A. Morrone, S. Malvagia, R. J. Wanders, W. Kulik, and F. M. Vaz. 2009. The enigmatic role of tafazzin in cardiolipin metabolism. Biochim. Biophys. Acta. 1788: 2003-2014.
39. Schlame, M. 2008. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J. Lipid Res. 49: 1607-1620.
40. Taylor, W. A., and G. M. Hatch. 2009. Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1). J. Biol. Chem. 284: 30360-30371.
41. Acehan, D., Z. Khuchua, R. H. Houtkooper, A. Malhotra, J. Kaufman, F. M. Vaz, M. Ren, H. A. Rockman, D. L. Stokes, and M. Schlame. 2009. Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria. Mitochondrion. 9: 86-95.
42. Gu, Z., F. Valianpour, S. Chen, F. M. Vaz, G. A. Hakkaart, R. J. Wanders, and M. L. Greenberg. 2004. Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome. Mol. Microbiol. 51: 149-158.
43. Malhotra, A., I. Edelman-Novemsky, Y. Xu, H. Plesken, J. Ma, M. Schlame, and M. Ren. 2009. Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome. Proc. Natl. Acad. Sci. USA. 106: 2337-2341.
44. Valianpour, F., V. Mitsakos, D. Schlemmer, J. A. Towbin, J. M. Taylor, P. G. Ekert, D. R. Thorburn, A. Munnich, R. J. Wanders, P. G. Barth, et al. 2005. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J. Lipid Res. 46: 1182-1195.
45. Vaz, F. M., R. H. Houtkooper, F. Valianpour, P. G. Barth, and R. J. Wanders. 2003. Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism. J. Biol. Chem. 278: 43089-43094.
46. Schlame, M., M. Ren, Y. Xu, M. L. Greenberg, and I. Haller. 2005. Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids. 138: 38-49.
47. Lewin, M. B., and P. S. Timiras. 1984. Lipid changes with aging in cardiac mitochondrial membranes. Mech. Ageing Dev. 24: 343-351.
48. Moghaddas, S., M. S. Stoll, P. E. Minkler, R. G. Salomon, C. L. Hoppel, and E. J. Lesnefsky. 2002. Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria. J. Gerontol. A Biol. Sci. Med. Sci. 57: B22-B28.
49. Lands, W. E. 1960. Metabolism of glycerolipids. 2. The enzymatic acylation of lysolecithin. J. Biol. Chem. 235: 2233-2237.
50. Lands, W. E. 2000. Stories about acyl chains. Biochim. Biophys. Acta. 1483: 1-14.
51. Xu, Y., S. Zhang, A. Malhotra, I. Edelman-Novemsky, J. Ma, A. Kruppa, C. Cernicica, S. Blais, T. A. Neubert, M. Ren, et al. 2009. Characterization of tafazzin splice variants from humans and fruit flies. J. Biol. Chem. 284: 29230-29239.
52. Cao, J., Y. Liu, J. Lockwood, P. Burn, and Y. Shi. 2004. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J. Biol. Chem. 279: 31727-31734.
53. Cao, J., W. Shen, Z. Chang, and Y. Shi. 2009. ALCAT1 is a polyglycerophospholipid acyltransferase potently regulated by adenine nucleotide and thyroid status. Am. J. Physiol. Endocrinol. Metab. 296: E647-E653.
54. Bione, S., F. Tamanini, E. Maestrini, C. Tribioli, A. Poustka, G. Torri, S. Rivella, and D. Toniolo. 1993. Transcriptional organization of a 450-kb region of the human X chromosome in Xq28. Proc. Natl. Acad. Sci. USA. 90: 10977-10981.
55. Dahlberg, M. 2007. Polymorphic phase behavior of cardiolipin derivatives studied by coarse-grained molecular dynamics. J. Phys. Chem. B. 111: 7194-7200.
56. Dahlberg, M., and A. Maliniak. 2008. Molecular dynamics simulations of cardiolipin bilayers. J. Phys. Chem. B. 112: 11655-11663.
57. Domenech, O., A. Morros, M. E. Cabanas, M. T. Montero, and J. Hernandez-Borrell. 2007. Thermal response of domains in cardiolipin content bilayers. Ultramicroscopy. 107: 943-947.
58. Domenech, O., L. Redondo, L. Picas, A. Morros, M. T. Montero, and J. Hernandez-Borrell. 2007. Atomic force microscopy characterization of supported planar bilayers that mimic the mitochondrial inner membrane. J. Mol. Recognit. 20: 546-553.
59. Domenech, O., F. Sanz, M. T. Montero, and J. Hernandez-Borrell. 2006. Thermodynamic and structural study of the main phospholipid components comprising the mitochondrial inner membrane. Biochim. Biophys. Acta. 1758: 213-221.
60. Rog, T., H. Martinez-Seara, N. Munck, M. Oresic, M. Karttunen, and I. Vattulainen. 2009. Role of cardiolipins in the inner mitochondrial membrane: insight gained through atom-scale simulations. J. Phys. Chem. B. 113: 3413-3422.
61. Schlame, M. 2009. Formation of molecular species of mitochondrial cardiolipin 2. A mathematical model of pattern formation by phospholipid transacylation. Biochim. Biophys. Acta. 1791: 321-325.
62. Malhotra, A., Y. Xu, M. Ren, and M. Schlame. 2009. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species. Biochim. Biophys. Acta. 1791: 314-320.
63. Hulbert, A. J., N. Turner, J. Hinde, P. Else, and H. Guderley. 2006. How might you compare mitochondria from different tissues and different species? J. Comp. Physiol. B. 176: 93-105.
64. Gupta, S., M. R. Maurya, D. L. Stephens, E. A. Dennis, and S. Subramaniam. 2009. An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis. Biophys. J. 96: 4542-4551.